Frank I. Tarazi MBBS, PhD, MBA

Frank Tarazi, MBBS, Ph.D., MBA is an associate professor of Psychiatry at Harvard Medical School and director of the Laboratory in Pharmacoeconomics and Health Outcomes at McLean Hospital. He is a preclinical and clinical expert on Alzheimer’s disease, Parkinson’s disease, schizophrenia, depression, and ADHD. Dr. Tarazi has published over 120 original articles and reviews in highly cited scientific and medical journals. He has also published over 12 book chapters, including a chapter in the standard textbook “Goodman and Gilman’s The Pharmacological Basis of Therapeutics,” and co-edited a book entitled “Neurological and Psychiatric Disorders: From Bench to Bedside.” Dr. Tarazi is the associate editor of Pharmacology and Therapeutics and CNS Spectrums and serves on the editorial board of several other journals.

Dr. Tarazi is a fellow of the American College of Neuropsychopharmacology (ACNP), and a member of the American Psychiatric Association and the American Academy of Neurology. He is also a member of the World Economic Forum’s Global Council on Neurotechnologies.